Back to Authors

Pollack, Paul

A5110123093 | I168537998

Mayo Clinic

Eli Lilly (United States)

Citations 2

P304 Impact of mirikizumab on histologic measures of intestinal inflammation in a phase 2 study of patients with moderate-severe crohn’s disease

Poster presentations | June 18, 2023 | Volume: No volume available | Issue: No issue available | Pages: A210.1-A210

10.1136/gutjnl-2023-bsg.370

S897 Impact of Mirikizumab Therapy on Histologic Measures of Intestinal Inflammation in a Phase 2 Study of Patients With Moderately- to Severely-Active Crohn’s Disease

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S422-S423

10.14309/01.ajg.0000777120.59385.ef